Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 354,725 | 92,646 | 45,681 | 43,459 | 79,674 |
| Marketable Securities | 359,864 | 548,206 | 115,035 | 71,194 | N/A |
| TOTAL | $728,883 | $651,218 | $172,023 | $125,698 | $82,537 |
| Non-Current Assets | |||||
| PPE Net | 1,374 | 960 | 92 | 51 | N/A |
| Investments And Advances | 0 | 0 | 0 | 58 | 867 |
| Other Non-Current Assets | 4,476 | 3,503 | 3,431 | 5,628 | 344 |
| TOTAL | $5,850 | $4,463 | $3,523 | $5,737 | $1,211 |
| Total Assets | $734,733 | $655,681 | $175,546 | $131,435 | $83,748 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 21,898 | 7,665 | 11,118 | 11,991 | 1,385 |
| Accrued Expenses | 31,008 | 16,223 | 8,749 | 10,964 | 5,928 |
| Other current liabilities | N/A | N/A | N/A | N/A | 377 |
| TOTAL | $53,455 | $25,371 | $22,303 | $25,600 | $7,690 |
| Non-Current Liabilities | |||||
| Long Term Debt | 74,838 | 50,687 | 49,877 | 24,810 | 4,923 |
| Other Non-Current Liabilities | 1,919 | 2,468 | 1,681 | 4,117 | 1,543 |
| TOTAL | $76,757 | $53,155 | $51,558 | $28,927 | $6,466 |
| Total Liabilities | $130,212 | $78,526 | $73,861 | $54,527 | $14,156 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,356 | 63,748 | 54,452 | 44,261 | 27,053 |
| Common Shares | 71 | 64 | 44 | 28 | 21 |
| Retained earnings | -760,865 | -461,250 | -309,102 | -213,112 | -124,056 |
| Other shareholders' equity | 786 | 393 | 251 | -224 | 0 |
| TOTAL | $604,521 | $577,155 | $101,685 | $76,908 | $69,592 |
| Total Liabilities And Equity | $734,733 | $655,681 | $175,546 | $131,435 | $83,748 |